Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PLEXAR: Plasma Exchange in ACLF
NCT04051437Phase 3Unknown
- Sponsor
- Asian Institute of Gastroenterology
- Start
- Aug 2019
- Primary completion
- Mar 2020
01
Overview
Phase 3, randomised, open-label trial (2 arms), sponsored by Asian Institute of Gastroenterology. Primary endpoint: Overall Survival at 90 days. Status: unknown.
Beyond the preview
Go deeper on NCT04051437.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04051437.